喉癌分子切缘及临床因素与喉癌预后的相关性

doi:10.3969/j.issn.1671-7171.2018.05.017

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨喉癌分子切缘及临床因素与喉癌预后的相关性。【方法】收集2010年1月至2011年12月于本院行手术治疗的喉癌患者129例的临床资料,均随访至2016年9月或至终点事件死亡。以是否复发分为两组,复发组47例,未复发组82例;探讨两组喉癌分子切缘及临床因素与预后的相关性。【结果】复发组T₃~T₄期,中、低分化癌,伴颈淋巴结转移,肿瘤位于声门下的构成比例明显高于未复发组,差异有统计学意义(P＜0.05)。两组性别、年龄、术后放疗比较差异无统计学意义(P＞0.05)。复发组cyclind1表达、构成比例明显高于未复发组,差异有统计学意义(P＜0.05)。复发组P27阳性表达率低于未复发组,P53、eIF4E阳性表达率高于未复发组,差异有统计学意义(P＜0.05)。建立直线回归方程,经Spearman关系检验结果显示,分子切缘cyclind1表达与预后呈正相关(r=0.716,P=0.002);P53、eIF4E与预后呈正相关(r=0.616,0.928,P=0.014,0.000);P27与预后呈负相关(r=-0.741,P=0.012)。【结论】喉癌分子切缘与预后密切相关,同时伴颈淋巴结转移、T分期高、肿瘤位于声门下是影响喉癌预后的主要因素。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：喉肿瘤/病理学, 预后, 危险因素, 淋巴转移

Abstract：【Objective】 To investigate the relationship between molecular cutting edge and clinical factors of laryngeal carcinoma and its prognosis.【Methods】The clinical data of 129 patients with laryngeal cancer who underwent surgical treatment from January 2010 to December 2011 were collected. All patients were followed up until September 2016 or death at the end of the year, and were divided into two groups according to recurrent or not: recurrence group (47 cases) and non recurrence group (82 cases). The correlation between the molecular margin and clinical factors of the two groups of laryngocarcinoma and prognosis were discussed.【Results】The proportion of subglottic tumor in T₃~T₄ stage, middle and low differentiation carcinoma with cervical lymph node metastasis was significantly higher than that in the non-recurrence group (P<0.05). There was no significant difference in sex, age and postoperative radiotherapy between the two groups (P>0.05). The expression of cyclind1 and composition ratio in the recurrent group was significantly higher than that in the non-recurrence group (P<0.05). The positive expression rate of P27 in the recurrent group was lower than that in the non-recurrent group (P<0.05). The positive expression rate of P53 eIF4E was significantly higher than that of the non-recurrence group (P<0.05). The linear regression equation was established. The results of Spearman relation test showed that the expression of cyclind1 in the molecular cutting edge was positively correlated with the prognosis(r=0.716,P=0.002).P53 and eIF4E were positively correlated with the prognosis(r=0.616,0.928,P=0.014,0.000)and there was a negative correlation between the P27 and the prognosis(r=-0.741,P=0.012).【Conclusion】The molecular cut edge of laryngeal carcinoma is closely related to prognosis. At the same time, cervical lymph node metastasis accompanied, higher T stage and tumor located in the subglottic are the main factors affecting the prognosis of laryngeal carcinoma.

Key words： LaryngealNeoplasms/PA Prognosis RiskFactors LymphaticMetastasis

收稿日期: 2017-05-18

PACS:

R739.65

通讯作者: E-mail:gr522@sina.com

引用本文:

张红蕾, 李大鹏, 李佳, 吴春妍, 郭睿. 喉癌分子切缘及临床因素与喉癌预后的相关性[J]. 医学临床研究, 2018, 35(5): 886-888.
ZHANG Hong-lei, LI Da-peng, LI Jia, et al. Correlation between Molecular Margin and Clinical Factors of Laryngeal Carcinoma and its Prognosis. JOURNAL OF CLINICAL RESEARCH, 2018, 35(5): 886-888.

链接本文:

http://www.jcr.net.cn/CN/10.3969/j.issn.1671-7171.2018.05.017 或 http://www.jcr.net.cn/CN/Y2018/V35/I5/886

[1] 刘馨莲,殷舞,李淑蓉,等.细胞周期蛋白在喉癌组织中的表达及意义[J].实用癌症杂志,2011,26(6):585-587,595.
[2] 张军辉,严家芹,陈小兵,等.熊果酸对Hep-2细胞增殖的影响及机制研究[J].中国现代医学杂志,2015,25(12):7-10.
[3] Sidransky D, Boyle J, Koch W.Molecular screening. Prospects for a new approach.Arch Otolaryngol Head Neck Surg,1993,119(11):1187-1190.
[4] 刘瑛,王斌全,高伟,等.wnt/β-catenin信号通路关键蛋白及Mucin1在喉鳞状细胞癌上表达与相关研究[J].中国医药导报,2012,9(17):59-65.[5] 王莹,李文媛,贾桦,等.喉癌组织中VEGF-D表达与淋巴管生成及预后的关系[J].解剖科学进展,2011,17(2):116-120.
[6] 杨旋,周建荣,冯明亮,等.血清抗p53抗体在喉癌患者中的诊断意义[J].重庆医科大学学报,2011,36(5):524-526.
[7] 曹文枫,张立勇,张斌,等.SLP-2基因在喉鳞状细胞癌和乳腺浸润性癌组织中的表达及其与预后的关系[J].中华病理学杂志,2010,39(5):332-337.
[8] 段世宏,郭玉芬.基质金属蛋白酶-11和基质金属蛋白酶-7与喉癌浸润转移及预后的相关性[J].中国耳鼻咽喉头颈外科,2014,21(4):193-196.
[9] 王莹,李文媛,梁金花,等.SDF-1/CXCR4的表达与喉癌组织VEGF-C表达、淋巴管生成及预后的相关性[J].医学研究杂志,2012,41(8):50-54.
[10] 李文媛,刘艳翠,尹国华,等.喉癌中胶原和钙结合EGF域1的表达与VEGF-C和淋巴管生成及预后的关系[J].基础医学与临床,2013,33(9):1160-1164.
[11] 周学军,王晓凤,冯勇军,等.喉鳞癌组织中SMG-1、ATM和P53的表达及临床意义[J].南方医科大学学报,2016,36(1):50-55.
[12] 齐志勇,贾永峰,张治平,等.S100A4、Bcl-2、Survivin在喉癌组织中的表达及临床意义[J].现代中西医结合杂志,2014,23(9):929-932,969.
[13] 陈瑜,刘翠萍.手术治疗老年喉癌的临床疗效及其相关影响因素[J].中国老年学杂志,2013,33(5):1059-1060.
[14] Piazza C,Paderno A,Grazioli P,et al.Laryngeal exposure and margin status in glottic cancer treated by transoral laser microsurgery[J].Laryngoscope,2018,128(5):1146-1151.
[15] Kumar RV,Shenoy AM,Daniel R,et al.Cyclin D1, p53, MIB1, intratumoral microvessel density, and human papillomavirus in advanced laryngeal carcinoma: association with nodal metastasis[J].Otolaryngol Head Neek Surg.2004:131(4):509-513.
[16] Buyukbayram H,Cureoglu S,Arslan A,et al.Prognostic value of PCNA and mutant P53 expression in laryngeal squamous cell carcinoma[J].Cancer Invest,2004,22(2):195-202.